What is the DES drug scandal and why are victims demanding an inquiry?

The DES drug scandal involves a synthetic oestrogen prescribed to pregnant women from the 1940s to 1970s, linked to cancers and reproductive issues in women and their descendants, prompting victims to demand a public inquiry.

What health issues are associated with the DES drug?

The DES drug is linked to various cancers, including cervical and vaginal cancer (clear cell adenocarcinoma), as well as infertility and other reproductive abnormalities in those exposed and their offspring.

What actions are DES victims requesting from the UK government?

Victims are requesting a statutory public inquiry into the DES scandal and the implementation of an NHS screening program to identify and support those affected by the drug.

Home / Health / DES Drug Scandal: Victims Demand Inquiry

DES Drug Scandal: Victims Demand Inquiry

9 Feb

•

Summary

Victims meet Wes Streeting for a public inquiry into DES drug harm.
DES, prescribed from 1940-1970s, linked to cancers and infertility.
Campaigners seek an NHS screening program for affected individuals.

DES Drug Scandal: Victims Demand Inquiry

Victims of the controversial pregnancy drug diethylstilbestrol (DES) are urging Health Secretary Wes Streeting to launch a public inquiry into the 'silent scandal'. DES Justice UK, a group with over 500 members including affected daughters and granddaughters, is also calling for an NHS screening program.

This synthetic oestrogen was prescribed to approximately 300,000 pregnant women between 1940 and the 1970s to prevent miscarriage and other complications. It was later linked to clear cell adenocarcinoma, a rare cancer of the cervix and vagina, and other cancers like breast and pancreatic cancer.